Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.
Chronic lymphocytic leukemia (CLL) leads to significant immune system dysfunction. The predominant clinical presentation in 50% of patients involves recurrent, often severe, infections. Infections are also the most common (60-80%) cause of deaths in CLL patients. The scope of infections varies with...
Main Authors: | Marcin Pasiarski, Jacek Rolinski, Ewelina Grywalska, Agnieszka Stelmach-Goldys, Izabela Korona-Glowniak, Stanislaw Gozdz, Iwona Hus, Anna Malm |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4266633?pdf=render |
Similar Items
-
Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine
by: Jolanta Smok-Kalwat, et al.
Published: (2024-03-01) -
Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study
by: Violetta Opoka-Winiarska, et al.
Published: (2021-04-01) -
Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study
by: Violetta Opoka-Winiarska, et al.
Published: (2022-07-01) -
CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis
by: Monika Abramiuk, et al.
Published: (2020-09-01) -
ThymicPeptides Reverse Immune Exhaustion in Patients with Reactivated Human Alphaherpesvirus1 Infections
by: Anna Hymos, et al.
Published: (2020-03-01)